Unlock instant, AI-driven research and patent intelligence for your innovation.

Tacrolimus immunogen, anti-tacrolimus specific antigen and tacrolimus detection reagent

A tacrolimus, immunogenic technology, applied in immunoglobulins, specific peptides, measuring devices, etc., can solve the problems of complex processing, high cost, radiation hazards for operators, etc., and achieve high immunogenicity.

Active Publication Date: 2012-08-01
长沙博源医疗科技有限公司
View PDF7 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The pretreatment of HPLC and LC / MS / MS methods is complicated, time-consuming, costly and requires high personnel operation; radioimmunoassay has radioactive hazards for operators; and the reagents of fluorescence polarization method mainly rely on imports, which are extremely expensive

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Tacrolimus immunogen, anti-tacrolimus specific antigen and tacrolimus detection reagent
  • Tacrolimus immunogen, anti-tacrolimus specific antigen and tacrolimus detection reagent
  • Tacrolimus immunogen, anti-tacrolimus specific antigen and tacrolimus detection reagent

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0066] Tacrolimus immunogen, wherein R is N-O-(CH 2 ) 3 -COO-, the carrier is bovine serum albumin (Bovine Serum Albumin, BSA).

[0067] The preparation method is as follows:

[0068] Step 1. Synthesis of Tacrolimus Derivatives with Formula (III) Structure

[0069] (1) Preparation of compound 4-phthalimide oxybutyrate ethyl ester with formula (IV) structure:

[0070] First dissolve 15.0g, 93mmol N-hydroxy-phthalimide in 200mL dimethylformamide (DMF) to obtain N-hydroxy-phthalimide solution, then add 4.97g, 92mmol sodium methoxide (NaOMe) and 17.9g, 92mmol ethyl 5-bromovalerate, obtain the first mixed solution, the first mixed solution was stirred at 100 DEG C for 8-16 hours, add water after cooling, obtain the second mixed solution, The second mixed solution was extracted with diethyl ether, washed with concentrated sodium carbonate after extraction to obtain the first extract, and the first extract was dried over sodium sulfate to obtain 20 g, 78% yellow oil.

[0071] Br...

Embodiment 2

[0086] The preparation of anti-tacrolimus specific antibody, the preparation method is as follows:

[0087] (1) Dilute the tacrolimus immunogen synthesized in Example 1 to 1.5 mg / ml with phosphate buffered saline (PBS) to obtain an antigen solution, then mix the antigen solution with Freund's complete adjuvant, and conduct injection;

[0088] (2) After 2 to 3 weeks, inject the rabbit once with 1.0ml of the same antigen solution mixed with Freund's incomplete adjuvant, and then once every four weeks, twice in total, and extract the antiserum of the rabbit to obtain effective antibodies.

Embodiment 3

[0090] Preparation of tacrolimus detection reagent,

[0091] Raw materials: the specific anti-tacrolimus antibody in the above example 2, the tacrolimus enzyme-labeled conjugate and 3,3',5,5'-tetramethylbenzidine for conventional ELISA detection (3,3'5,5'-Tetramethylbenzidine, TMB) substrate solution.

[0092] The preparation method of tacrolimus enzyme-labeled conjugate is as follows:

[0093] Weigh 20mg of HRP and dissolve it in 5ml of 0.2M, pH 8.5 phosphate buffer at room temperature; weigh 5mg of tacrolimus derivative with the structure of formula (III) in a small beaker, and add 350μL of DMF, 350 μL of absolute ethanol, 700 μL of 10 mM potassium phosphate buffer at pH 5.0, 20 mg of EDAC and 3 mg of Sulfo-NHS were stirred and reacted at room temperature for 30 min; then the activated tacrolimus derivative was added dropwise to the HRP solution, and the Stir at -8°C for 8-16 hours, and dialyze and purify the coupled antigen to obtain a HRP-tacrolimus conjugate.

[0094] ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a tacrolimus immunogen, an anti-tacrolimus specific antigen and a detection reagent. The structural formula of the tacrolimus immunogen is shown as a formula (I), wherein R is a connecting group; and a carrier has immunogenicity. The tacrolimus immunogen disclosed by the invention has high immunogenicity, and can be used for inducing the preparation of a high-valence anti-tacrolimus specific antigen. The anti-tacrolimus specific antigen disclosed by the invention has high specificity, high bonding force with tacrolimus and higher sensitivity than the conventional anti-tacrolimus antigen.

Description

technical field [0001] The invention belongs to the field of biotechnology and relates to a tacrolimus immunogen, an anti-tacrolimus specific antibody and a tacrolimus detection reagent. Background technique [0002] Tacrolimus (Tacrolimus, FK506), its structural formula is shown in formula (II). [0003] [0004] Formula (II) [0005] Tacrolimus is an immunosuppressant, which is commonly used for organ transplantation, especially for kidney transplant patients. Rational administration of tacrolimus after transplantation can prevent organ rejection. Insufficient dose of tacrolimus can lead to rejection of transplanted organs; excessive dose can cause serious side effects, including kidney toxicity, liver toxicity and a series of other complications. The most effective way to ensure the immunosuppression of organ transplant recipients is to detect the concentration of tacrolimus in the patient's whole blood and to rationally use the drug in combination with other clinica...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K14/765C07K14/795C07K14/435C07K16/44G01N33/543C07D498/18
Inventor 虞留明田军袁红霞蔡江丽
Owner 长沙博源医疗科技有限公司